Brid Devlin, PhD

Dr. Devlin is responsible for drug development projects at IPM. Before assuming her role as executive vice president for product development, she served as IPM’s director of formulation technology, directing formulation and manufacturing sciences of vaginal rings, gels and films.

Prior to joining IPM, Dr. Devlin worked at the global pharmaceutical company Sanofi-Aventis for seven years, during which she served as both the assistant director and group leader as well as the senior manager and head of the Pharmaceutical Sciences Department. In those roles, Dr. Devlin was responsible for directing formulation development of solid and semi-solid dosage forms for global markets, and for packaging development of therapeutic compounds. Dr. Devlin has also worked as research group leader at Biosyn, and as a research associate at McNeil Consumer Healthcare.

Dr. Devlin received her BS in biology, chemistry and mathematics from the National University of Ireland, Maynooth, and her PhD in pharmaceutics from the University of the Sciences in Philadelphia.